Vaughan & Co Securities
CVS icon

Vaughan & Co Securities’s CVS Health CVS Stock Holding History

Vaughan & Co Securities’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$541K Sell
6,314
-1,634
-21% -$160K 0.25% 42
2026
Q2 		$822K Sell
7,948
-436
-5% -$38.9K 0.38% 25
2026
Q1 		$602K Sell
8,384
-344
-4% -$26.5K 0.31% 40
2025
Q4 		$693K Sell
8,728
-378
-4% -$29.8K 0.36% 29
2025
Q3 		$687K Sell
9,106
-4,165
-31% -$285K 0.36% 34
2025
Q2 		$915K Hold
13,271
– – 0.53% 19
2025
Q1 		$899K Buy
+13,271
New +$794K 0.56% 19

Other funds holding CVS

Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Canoe Financial
Canoe Financial Calgary, Alberta, Canada $8.31B AUM 20.77% 1-Year Est. Return
Hamlin Capital Management
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Vaughan & Co Securities's CVS Position: Q3 2026 in Review

Vaughan & Co Securities reduced its CVS Health (CVS) stake by 21% in Q3 2026, selling an estimated $160K and leaving 6,314 shares worth $541K. The position accounts for 0.25% of the portfolio, ranked #42.

Vaughan & Co Securities first reported a position in CVS in Q1 2025 and has held it in 7 quarters since. The position peaked at $915K in Q2 2025. 808 funds tracked by Wall St. Rank hold CVS as of Q3 2026.

  • Vaughan & Co Securities held 6,314 shares of CVS Health worth $541K as of Q3 2026.
  • Vaughan & Co Securities sold 1,634 CVS Health shares in Q3 2026, an estimated $160K.
  • CVS Health made up 0.25% of Vaughan & Co Securities's portfolio in Q3 2026, its #42 holding.
  • Vaughan & Co Securities first reported a position in CVS Health in Q1 2025 and has held it in 7 quarters since.
  • Vaughan & Co Securities's CVS Health position peaked at $915K in Q2 2025.
  • 808 funds tracked by Wall St. Rank held CVS Health as of Q3 2026.

Based on Vaughan & Co Securities's 13F filing for Q3 2026, filed 23 Oct 2026.